BRCA tests will be added to the MBS: Here's what it means for GPs
BRCA genetic tests for breast and ovarian cancer will be added to the MBS from 1 November.
The new items will allow cancer specialists to order tests for BRCA1 and BRCA2 genes for patients with breast or ovarian cancer who have risk factors – such as family history - suggestive of heritable mutations.
BRCA tests will also be available for family members of patients who test positive.
Dr Melody Caramins, chair of the Royal College of Pathologists of Australasia Genetic Advisory Committee, said the listing was a “huge milestone” that would improve access to screening and